Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 420-640-8 | CAS number: 138495-42-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
Oral: Testing has been waived. Inhalation is the most plausible route for repeated exposures.
Dermal: Testing has been waived. Inhalation is the most plausible route for repeated exposures.
Inhalation: OECD 413. 90-day inhalation, 6 hr/day, rats. No local effects observed. No effects observed at 5154 mg/m3. Systemic effects (central nervous system) were observed at 20618 mg/m3 and higher. Effects were the same as those observed in acute toxicity studies, and neither severity nor rate of incurrence increased with increasing exposure duration, e.g., toxicity was not progressive with exposure. Therefore, there is no repeated exposure contribution to toxicity. When all of the relevant data were considered, the NOAEL for central nervous system effects (in both extended repeated exposures or acute exposures) was 15463 mg/m3. Not classified as a repeated exposure toxin. Reliability = 1.
Key value for chemical safety assessment
Repeated dose toxicity: inhalation - systemic effects
Endpoint conclusion
- Dose descriptor:
- NOAEC
- 15 463 mg/m³
- Study duration:
- subchronic
- Species:
- rat
Additional information
The only toxicity observed in the subchronic study was associated with central nervous system effects, e. g. tremors and convulsions, which occur at a threshold exposure concentration of 20618 mg/m3. No adverse effects were observed at 5154 mg/m3 and lower. The central nervous system effects in the subchronic study were the same as those observed in acute toxicity studies, and neither severity nor rate of occurrence changed with increasing exposure duration, e.g. toxicity was not progressive with exposure. There is no apparent concentration/time (C x T) relationship that would support treating the toxicity as increasing with exposure duration or time span. Therefore, acute and repeated exposure toxicity effects are identical for this substance. If the 90-day inhalation study is taken in isolation, the NOAEL would be 500 ppm (5154 mg/m3) for males and females based on the clinical signs of central nervous system toxicity observed during exposure concentrations of 2000 ppm (20618 mg/m3) and above. However, in the 90-day study, all adverse central nervous system effects occurred very early in the exposure and presented in the same manner as the effects in the acute inhalation, neurotoxicity, developmental and reproductive studies. The adverse effects did not increase in severity or occurrence with increasing exposure duration. Therefore, the nature of the adverse effects associated with test substance provided a unique opportunity to use a 2-hr neurotoxicity study (DI.K2.2-hr.NEURO.HLR-395-95) to evaluate the toxicity between the 500 and 2000 ppm exposure levels used in the 90-day subchronic study. When all of the relevant data were considered, the NOAEL for central nervous system effects (in both extended repeated exposures or acute exposures) was 15463 mg/m3.
Repeated dose toxicity: inhalation - systemic effects (target organ) neurologic: central nervous system
Justification for classification or non-classification
Based on the high exposure concentrations necessary to produce adverse effects, and the observations during the acute and repeated exposure inhalation exposures, the substance does not need to be classified for repeated dose toxicity according the EU Directive 67/548/EEC and EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)